Our findings support that plaques contain proteolytically active PAPP-A, that can be released by ex vivo incubation, and that PAPP-A associates with other components of the IGF-system within plaque tissue suggesting that the IGF-system has a role even in late stages of atherosclerosis within a therapeutically relevant window. This evidence concerns the gene IGF1 and atherosclerosis.